Five challenges in the design and practice of implementation science trials for HIV prevention and treatment
Identifying programme implementation strategies that most effectively strengthen the HIV treatment and prevention cascades in Africa is a pressing global priority. Rigorous trials that compare outcomes under different strategies have a role to play. However, there are challenges associated with making such trials: Feasible to undertake, Useful for onward policy making, Rigorous and unbiased, Relevant to “real-life” and Informative. In other words, they need to be FURRI, but making them so is not simple. This lecture will discuss these challenges (and some possible solutions), with examples from the field of HIV prevention and treatment.
About the speaker
James Hargreaves is Professor of Epidemiology and Evaluation at the London School of Hygiene and Tropical Medicine. His primary interest has been in the socioeconomic epidemiology of HIV/AIDS and tuberculosis in sub-Saharan Africa and in developing and evalauting interventions to address these public health issues. James is also the Director for the MeSH Consortium.